PLoS ONE (Jan 2014)

Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia.

  • Yu-Shuang Chai,
  • Zhi-Yi Yuan,
  • Fan Lei,
  • Yu-Gang Wang,
  • Jun Hu,
  • Feng Du,
  • Xi Lu,
  • Jing-Fei Jiang,
  • Dong-Ming Xing,
  • Li-Jun Du

DOI
https://doi.org/10.1371/journal.pone.0090850
Journal volume & issue
Vol. 9, no. 6
p. e90850

Abstract

Read online

Berberine is one kind of isoquinoline alkaloid with anti-apoptotic effects on the neurons suffering ischemia. To address the explanation for these activities, the berberine-induced cell cycle arrest during neurons suffering ischemia/reperfusion had been studied in the present study. According to the in vitro neurons with oxygen-glucose deprivation and in vivo ICR mice with cerebral ischemia/reperfusion, it was found that berberine could protect the mRNA of retinoblastoma (Rb) from degradation through its function on the poly(A) tail. The prolonged half-life of retinoblastoma 1 (gene of Rb, RB1) mRNA level secures the protein level of retinoblastoma, which facilitates cell cycle arrest of neurons in the process of ischemia/reperfusion and subsequently avoids cells entering in the apoptotic process. The poly(A) tail of RB1 mRNA, as a newly identified target of berberine, could help people focus on the interaction between berberine and mRNA to further understand the biological activities and functions of berberine.